SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SNDX is currently covered by 10 analysts with an average price target of $29.13. This is a potential upside of $16.16 (124.6%) from yesterday's end of day stock price of $12.97.

Syndax Pharmaceuticals's activity chart (see below) currently has 105 price targets and 110 ratings on display. The stock rating distribution of SNDX is 93.75% BUY and 6.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.26% with an average time for these price targets to be met of 223.25 days.

Highest price target for SNDX is $51, Lowest price target is $17, average price target is $34.4.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 05-Aug-2025. First documented stock forecast 31-Mar-2016.

Currently out of the existing stock ratings of SNDX, 45 are a BUY (93.75%), 3 are a HOLD (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$51

$38.28 (300.94%)

$42

8 days ago
(05-Aug-2025)

3/11 (27.27%)

$38.43 (305.73%)

355

Buy

$18

$5.28 (41.51%)

$33

1 months 3 days ago
(10-Jul-2025)

0/3 (0%)

$8.18 (83.30%)

Buy

$32

$19.28 (151.57%)

$43

3 months 7 days ago
(06-May-2025)

0/4 (0%)

$21.36 (200.75%)

Hold

$17

$4.28 (33.65%)

$16

3 months 7 days ago
(06-May-2025)

2/5 (40%)

$6.36 (59.77%)

34

Buy

$41

$28.28 (222.33%)

$39

4 months 24 days ago
(20-Mar-2025)

0/10 (0%)

$26.9 (190.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 223.25 days on average for the stock forecasts to be realized with a an average price target met ratio 25.26

Which analyst has the current highest performing score on SNDX (Syndax Pharmaceuticals) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Yigal Nochomovitz with highest potential upside - $38.28

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

George Farmer with lowest potential downside - $4.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?